Reversibility of Dysmotility After Gastric Banding
Reversibility of Esophageal Dysmotilities Associated With Gastric Banding After Conversion to Gastric Bypass
Study Overview
Status
Detailed Description
2.2.3 Research plan
As model for this study we propose a longitudinal single-center study design with testing before and after the surgical intervention.
Participants
The study population will be limited to patients considered for gastric banding to gastric by-pass conversion. Patients will be recruited from the surgical out-patient clinic
Testing during the study period
Pre-OP 3 months post-OP Symptom evaluation X X Endoscopy X X Upper GI series X X Combined MII-EM X X
OP - conversion of gastric band to gastric bypass
After providing informed consent the volunteers will be screened for inclusion/exclusion criteria. Participants fulfilling the inclusion/exclusion criteria will undergo baseline symptom evaluation, endoscopy, an upper GI series and esophageal function testing using combined MII-EM as part of the pre-operative work-up. The same examinations (symptom evaluation, endoscopy, upper GI series and esophageal function testing) will be repeated 3 months after successful conversion from gastric band to bypass.
Symptom evaluation Patients will be asked to complete a standardized esophageal symptom questionnaire. This questionnaire evaluates the frequency and severity of heartburn, chest pain, regurgitation and dysphagia which are then computed into a composite score (Eraflux score ).
Endoscopy Standard sedated endoscopy will be performed by a trained gastroenterologist. The endoscopy will be performed according to the standard clinical protocol. During endoscopy the examiner will pay particular attention to the esophageal mucosa, the size of the gastric pouch above the band (baseline examination), the size of the gastric pouch above the gastro-jejunal anastomosis (post-operative examination), the presence of ulcerations at the site of gastric banding/gastric bypass.
Upper GI Series Patients will undergo upper GI series using a modified timed-barium swallow (achalasia) protocol. Patients will receive 100ml liquid barium and PA images focused on the GE junction will be taken immediately after swallowing, 1 and 3 minutes later. These sequences should allow determining the position of the band relative to the GE junction and the size of the gastric pouch above the gastro-jejunal anastomosis.
Esophageal function testing (EFT)
On the day of esophageal motility testing an EFT probe will be placed transnasally through the esophagus into the stomach and the LES location and pressure will be determined by stationary pull-through technique. The most distal circumferential pressure sensor will be placed in the high-pressure zone (HPZ) of the LES. The other measuring sites (both pressure and impedance) will be subsequently at 5, 10, 15 and 20 cm above the HPZ of the LES. Ten swallows (5 cc each) of liquid (0.9% normal saline) and 10 swallows (5 cc each) of a standard viscous material (EFT viscous, Sandhill Scientific, Inc) will be given with each swallow 20-30 seconds apart.
Analyzed parameters:
- Bolus transit time (BTT): time interval (sec) between bolus entry at the proximal measuring segment and bolus exit at the distal segment
- Smooth muscle bolus transit time (SMBTT): time interval (sec) between bolus entry at the second most distal measuring segment and bolus exit at the distal segment
- Contraction amplitude at 5, 10, 15 and 20 cm above the HPZ
- Distal esophageal amplitude (DEA): average amplitude of contraction at 5 and 10cm above HPZ
- Onset velocity of contractions: contraction velocity between 5 and 10 cm above the HPZ
- LES mid-respiratory resting pressure measured during station pull-through
- Average LES residual pressure during swallowing
Data analysis
Proportions (i.e. percentage of patients with esophageal dysmotility, patients with ulcerations at the banding/anastomosis site, etc.) will be compared using McNemar test. Continuous parameters (i.e. symptom scores, esophageal manometry and bolus transit data) recorded prior and 3-months after the conversion will be compared using paired T-tests. For statistical significance alpha will be set at 0.05.
Sample size calculation Assuming that esophageal dysmotilities are present in 50% of patients prior to the conversion of banding to bypass and that conversion reduces this proportion by 50% we calculated that 40 complete datasets would be required for an 85% power to identify this change. Allowing a drop-out rate of 20% we plan to enroll 50 patients in the present study.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
St. Gallen, Switzerland
- Cantonal Hospital St. Gallen
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients in whom a conversion from gastric band to gastric bypass is planed
Exclusion Criteria:
- Acute cardiac or pulmonary conditions
- Antireflux surgery or antireflux endoscopic procedures.
- Patients unable to provide informed consent
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
1
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
reversibility of dysmotility after surgery
Time Frame: 3 months
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
degree of dysmoztility after gastric banding
Time Frame: not defined
|
not defined
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: Patrizia Kuenzler, study nurse, Cantonal Hospital St. Gallen
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- EKSG 06/91
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.